The Metastatic Prostate Cancer Project (MPCproject.org) has released the first of many publicly available datasets to come from this nationwide genomic research initiative designed for men with advanced or metastatic prostate cancer. Comprised of clinical, genomic and patient reported data from 19 patient-partners, the data has been shared in cBioPortal, a public scientific portal, as an initial step toward the development of a much larger and more comprehensive dataset. You can read more about and link to the data here MPCproject.org/data-release.
MPCP is being conducted at the Broad Institute of MIT and Harvard in collaboration with Dana-Farber Cancer Institute, and it takes a new approach to genomic research by working directly with men with advanced and metastatic prostate cancer. When patients sign up for the project, they provide information about their experiences with their disease and where they have been seen for treatment. In addition, patients provide their medical records as well as tissue and/or blood samples for genomic analysis. The goal of MCPC is to create the most comprehensive prostate cancer database that will be shared with the entire research community and enable scientists to look at patient-provided, de-identified data, tumor samples, clinical information and more — allowing for more exhaustive research into prostate cancer and its treatment.
Data will continue to be released as it is generated so that the entire research community can have access to it. As the dataset gets larger, researchers will be able to gain more insights. This means that the more men that participate in the project, the more successful it will be. If you have metastatic or advanced prostate cancer, please join the 650+ men who already signed up to participate. Every man makes a difference, so get counted.
In February 2019, FANS for the CURE announced our ongoing partnership with MPCP. We are proud to support the entire MPCP team and this game changing initiative to accelerate discoveries and better treatments for prostate cancer. Plays like this will help win the war against prostate cancer. Take a moment and GET COUNTED!